Denosumab and Osteoporotic Vertebral Compression Fracture
NCT05058443
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Osteoporotic Vertebral Compression Fracture
Interventions
DRUG:
Denosumab 60 mg/ml [Prolia]
DRUG:
Placebo
Sponsor
Shenzhen People's Hospital